marcus evans europe conferences

Strategic Technology & Process Transfer in Commercialising Biologics

Successfully Translating Your Bioprocesses and Manufacturing Hurdles into Commercial Reality

12-14 March 2014
Le Meridien, Vienna, Austria

Conference Workshop

Half Day Site Visit and Tour:

Contract Manufacturing of Biopharmaceuticals – Tech Transfer and Scale Up Concepts for Early, Mid and Late Stage Processes

Workshop Moderator:

Company: Boehringer Ingelheim RCV GmbH & Co KG, Vienna


Why You Should Attend

Strategic Technology & Process Transfer in Commercialising Biologics

Technology and Process Transfer forms an inherent part of biopharmaceutical drug realisation and occurs at key stages throughout the product development lifecycle. It provides an important function in ensuring controlled knowledge, process and product transitioning between development and subsequent internal or outsourced clinical and commercial manufacturing stages. Technology Transfer can easily make the difference between a successful or failed project and it is therefore essential in getting it right the first time.

 

However there are still many Technology Transfer challenges from clinical stages to commercial manufacturing that do not have a standard practice. Delegates will learn how to best manage and design their control strategy in ensuring quality process transfer and scale up for commercialisation. As the fierce competition to reach the market continues, delegates are interested in how they could reduce time and cost while minimising the risk of failed manufacturing and benchmark from their peers.

 

By attending this exclusive marcus evans conference, delegates will benefit from finding tools to overcome bioprocessing, regulatory and manufacturing challenges to achieve a smooth transition into the market. Come and share your experiences with leading decision makers to streamline your clinical success!

 

 

Who Should Attend:

Directors, CEOs, VPs, Directors, Heads of:

  • Manufacturing Science/Technology (MS&T)
  • Knowledge/Technology Management
  • Technology Development
  • Bioprocessing/Processing
  • Biologics/ Biopharmaceutical Operations
  • Bioproduction
  • Downstream Process
  • Contract Manufacturing
  • Business Development
  • CMC
  • Quality

 

 

From:

     Pharma Companies

     Biotech Companies

     Service Providers

     CMOs

     CROs

 

 


Key Topics

  • Learn best-in-class business strategies to secure the future of your biologics
  • Discover new technologies and tools to improve commercial bioprocessing and manufacturing
  • Stay ahead of the regulatory progress and market access considerations
  • Gain insight from the CMO perspective and design a road map to collaborative manufacturing
  • Leverage experiences from leading pharmaceutical companies and decision makers

  • Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.




    Event Partners

    • border=0

    • border=0

    • border=0

    • border=0

    • border=0

    • border=0

    • border=0

    • border=0


    Practical Insights From

    Carl Jone
    Director, Analytical Development Biologicals & Knowledge Management
    UCB Pharma

    Michael Kraus
    Director Process Knowledge & Management
    Baxter Healthcare

    Ulrich Ruemenapp
    Contract Manufacturing Biotech, Head Biotech Projects
    Bayer AG

    Oliver Stauch
    Head Pharmaceutical Processing & Technology Development
    Genentech

    Roland Schmidt
    Senior Group Leader, Late-Stage Pharmaceutical & Processing, Processing Development
    F. Hoffmann-La Roche AG

    Peter Jones
    Lead, Manufacturing Sciences & Technology
    Oxford BioMedica

    Ciarán Tobin
    Validation & Technical Standards Lead
    Pfizer

    David Brühlmann
    Process Coordinator, Large Scale Biotech Operations
    Merck Serono SA

    Click Here For Full Agenda

    Voice of Our Customers
    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Kristiyan Sokolov


    PO Box 24797
    CY-1304 Nicosia
    Cyprus

    Telephone:
    +357 22 849 408
    Fax: +357 22849 394
    Email: KristiyanS@marcusevansuk.com